List of Theravance patents

Patents where

Current Assignee

Name

Theravance

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11390603 Crystalline forms of a biphenyl compound	Patent 11390603 was granted and assigned to Theravance on July, 2022 by the United States Patent and Trademark Office.	Theravance	Theravance	United States Patent and Trademark Office	11390603	July 19, 2022
‌ US Patent 7604944 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same	Patent 7604944 was granted and assigned to Theravance on October, 2009 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	7604944	October 20, 2009
‌ US Patent 7585653 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same	Patent 7585653 was granted and assigned to Theravance on September, 2009 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	7585653	September 8, 2009
‌ US Patent 7179794 Multivalent macrolide antibiotics	Patent 7179794 was granted and assigned to Theravance on February, 2007 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	7179794	February 20, 2007
‌ US Patent 11649209 Crystalline freebase forms of a biphenyl compound	Patent 11649209 was granted and assigned to Theravance on May, 2023 by the United States Patent and Trademark Office.	Theravance	Theravance	United States Patent and Trademark Office	11649209	May 16, 2023
‌ US Patent 10251874 Crystalline forms of a JAK inhibitor compound	Patent 10251874 was granted and assigned to Theravance on April, 2019 by the United States Patent and Trademark Office.	Theravance	Theravance	United States Patent and Trademark Office	10251874	April 9, 2019
‌ US Patent 9249099 Crystalline forms of a biphenyl compound	Patent 9249099 was granted and assigned to Theravance on February, 2016 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	9249099	February 2, 2016
‌ US Patent 9656993 Crystalline forms of a biphenyl compound	Patent 9656993 was granted and assigned to Theravance on May, 2017 by the United States Patent and Trademark Office.	Theravance	Theravance	United States Patent and Trademark Office	9656993	May 23, 2017
‌ US Patent 7858583 Process for purifying glycopeptide phosphonate derivatives	Patent 7858583 was granted and assigned to Theravance on December, 2010 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	7858583	December 28, 2010
‌ US Patent 7700777 Crystalline forms of a biphenyl compound	Patent 7700777 was granted and assigned to Theravance on April, 2010 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	7700777	April 20, 2010
‌ US Patent 10577347 Crystalline forms of a biphenyl compound	Patent 10577347 was granted and assigned to Theravance on March, 2020 by the United States Patent and Trademark Office.	Theravance	Theravance	United States Patent and Trademark Office	10577347	March 3, 2020
‌ US Patent 8716313 Crystalline forms of a biphenyl compound	Patent 8716313 was granted and assigned to Theravance on May, 2014 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	8716313	May 6, 2014
‌ US Patent 8242137 Crystalline forms of a biphenyl compound	Patent 8242137 was granted and assigned to Theravance on August, 2012 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	8242137	August 14, 2012
‌ US Patent 10548886 Methods of treatment using a JAK inhibitor compound	Patent 10548886 was granted and assigned to Theravance on February, 2020 by the United States Patent and Trademark Office.	Theravance	Theravance	United States Patent and Trademark Office	10548886	February 4, 2020
‌ US Patent 8377965 Crystalline forms of a biphenyl compound	Patent 8377965 was granted and assigned to Theravance on February, 2013 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	8377965	February 19, 2013
‌ US Patent 10406148 Methods of treatment using a JAK inhibitor compound	Patent 10406148 was granted and assigned to Theravance on September, 2019 by the United States Patent and Trademark Office.	Theravance	Theravance	United States Patent and Trademark Office	10406148	September 10, 2019
‌ US Patent 11008289 Crystalline freebase forms of a biphenyl compound	Patent 11008289 was granted and assigned to Theravance on May, 2021 by the United States Patent and Trademark Office.	Theravance	Theravance	United States Patent and Trademark Office	11008289	May 18, 2021
‌ US Patent 10550081 Crystalline freebase forms of a biphenyl compound	Patent 10550081 was granted and assigned to Theravance on February, 2020 by the United States Patent and Trademark Office.	Theravance	Theravance	United States Patent and Trademark Office	10550081	February 4, 2020
‌ US Patent 9226896 Crystalline freebase forms of a biphenyl compound	Patent 9226896 was granted and assigned to Theravance on January, 2016 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	9226896	January 5, 2016
‌ US Patent 8101766 Crystalline form of a biphenyl compound	Patent 8101766 was granted and assigned to Theravance on January, 2012 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	8101766	January 24, 2012
‌ US Patent 10100013 Crystalline freebase forms of a biphenyl compound	Patent 10100013 was granted and assigned to Theravance on October, 2018 by the United States Patent and Trademark Office.	Theravance	Theravance	United States Patent and Trademark Office	10100013	October 16, 2018
‌ US Patent 7452861 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent	Patent 7452861 was granted and assigned to Theravance on November, 2008 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	7452861	November 18, 2008
‌ US Patent 7521418 Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent	Patent 7521418 was granted and assigned to Theravance on April, 2009 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	7521418	April 21, 2009
‌ US Patent 7368463 Substituted 4-amino-1-benzylpiperidine compounds	Patent 7368463 was granted and assigned to Theravance on May, 2008 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	7368463	May 6, 2008
‌ US Patent 7524880 Crystalline form of a substituted pyrrolidine compound	Patent 7524880 was granted and assigned to Theravance on April, 2009 by the United States Patent and Trademark Office.		Theravance	United States Patent and Trademark Office	7524880	April 28, 2009

...

Results per page:

605 results

0 selected

605 results

0 selected